Could a 6-Day steroid pill reduce opioid needs after surgery?

NCT ID NCT06780202

Recruiting now Symptom relief Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a 6-day course of the steroid Medrol (methylprednisolone) can lower pain, nausea, and the need for opioid painkillers after foot or ankle surgery. About 180 adults having surgery at Emory will take either the steroid or a placebo, plus a small supply of hydrocodone for breakthrough pain. The goal is to see if the steroid helps people recover with fewer opioids and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Methylprednisolone (a corticosteroid, given as a 6-day tapering course)
What this could lead to: If it works, this could offer a way to manage post-surgery pain with fewer opioids, lowering the risk of dependence.
What could go wrong: This is a small Phase 2 trial, so results are preliminary. The steroid may not reduce pain or nausea significantly, and it carries risks like infection or delayed wound healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACHILLES TENDON INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankle injury disease Foot Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACHILLES TENDON INJURY ANKLE INJURIES AND DISORDERS FOOT INJURIES AND DISORDERS

Contacts and locations

Locations

Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center
RECRUITING

Atlanta, Georgia, 30329, United States
Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center
RECRUITING

Johns Creek, Georgia, 30022, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.